Ozempic competitors show there’s much to gain in weight loss drugs
Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.
Why Illumina Stock Got Mashed on Monday
On Monday, for the second time in as many business days, Illumina ( ILMN -5.47%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6% ...
e.l.f. Beauty’s (ELF) “Equal Weight” Rating Reaffirmed at Morgan Stanley
Morgan Stanley reaffirmed their equal weight rating on shares of e.l.f. Beauty (NYSE:ELF – Free Report) in a research note ...
Waters upgraded to Equal Weight from Underweight at Barclays
Barclays upgraded Waters (WAT) to Equal Weight from Underweight with a price target of $415, up from $360. The firm says the company’s “upgrade ...
SDVD: 8.5% Yield, Good Fundamentals, And A Red Flag
SDVD holds dividend growth stocks and sells short-term call options on the Russell 2000 Index. Read more to see my ...
news.stocktradersdaily1d
When the Price of (EQL.F) Talks, People Listen
February 08, 2025, 11:08 PM ET, BY John, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...
GSEW: Value And Diversification
The Goldman Sachs Equal Weight U.S. Large Cap Equity ETF is an equal-weight ETF holding about 500 stocks, rebalanced twice a ...
This ETF briefly beat the S&P 500 in 2025. Why one analyst remains cautious.
Despite briefly outperforming the cap-weight S&P 500 in 2025, RSP has widely lagged its more popular counterpart in the current bull market, up only 42% compared with its counterpart's nearly 70% ...
Psychology Today4d
Ozempic for the Rich, Body Positivity for the Poor
Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...